Standard BioTools Inc. Restricted Cash and Cash Equivalents
Standard BioTools Inc. (LAB) had Restricted Cash and Cash Equivalents of $795.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2023-05-09
- 2023-03-31: Restricted Cash and Cash Equivalents $795.00K.
- 2022-12-31: Restricted Cash and Cash Equivalents $1.01M.
- 2022-09-30: Restricted Cash and Cash Equivalents $1.01M.
- 2021-12-31: Restricted Cash and Cash Equivalents $1.02M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2023-03-31 | $795.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.01M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $1.01M 10-Q · filed 2022-11-09 |
| 2021-12-31 | $1.02M 10-K · filed 2023-03-14 |
| 2021-06-30 | $1.02M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $1.02M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $1.02M 10-Q · filed 2021-05-07 |
| 2020-09-30 | $1.01M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.07M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.07M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.08M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.08M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.08M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |